SUMMARY

A citizen submitted a request for access to information addressed to the Ministry of Health to obtain reports or studies on the savings due to the marketing and financing of the drug Varenicline, as well as the reasons for such marketing.

The Ministry did not respond to the request for information

When a complaint was filed, the Council of Transparency and Good Governance estimated it in the part relating to economic studies on the savings in the marketing of the drug, since there are no limits or causes of inadmissibility applicable.